GENELINK, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | +900.00% |
| 2015 | GeneLink Inc. Emerged from Bankruptcy | CI |
| 2015 | Second Amended Reorganization Plan and Disclosure Statement Approved for GeneLink Inc. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Medical & Diagnostic Laboratories
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 2.65K | - | - | - | - | - | |
| 8.05B | ||||||
| 4.32B | - | - | ||||
| 2.74B | ||||||
| 2.6B | ||||||
| 1.97B |
- Stock Market
- Equities
- GNLK.Q Stock
- Charts GeneLink, Inc.
- Sector Chart